We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BCT market cap is 169.41M. The company's latest EPS is USD -1.2703 and P/E is -8.34.
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.54M | -2.95M | -5.55M | -15.29M | -23.27M |
| Net Income | -5.79M | -4.03M | -428k | -26.84M | -20.3M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 546k | 522k | 58.04M | 42.58M | 27.16M |
| Total Liabilities | 1.39M | 4.12M | 782k | 32.25M | 30.94M |
| Total Equity | -846k | -3.6M | 57.26M | 10.33M | -3.78M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.09M | -1.27M | -7.75M | -12.48M | -23.75M |
| Investing | 1.34M | N/A | N/A | N/A | N/A |
| Financing | 3M | 1.17M | 64.99M | -3.74M | 3.95M |
| Market Cap | 169.41M |
| Price to Earnings Ratio | -8.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.97 |
| Price to Book Ratio | -44.85 |
| Dividend Yield | - |
| Shares Outstanding | 15.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.55 (4.98%) |
| Company Name | BriaCell Therapeutics Corp |
| Address |
suite 300 – 235 west 15th street vancouver, british columbia V7T 2X1 |
| Website | https://www.briacell.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
